EPA Considers First Protein-Based Biocontrol for Fruit and Vegetable Diseases
January 22, 2021 Biotalys NV announced that it has submitted its first protein-based biocontrol, Evoca, to the EPA in the U.S. for approval. Pending EPA registration, the biocontrol will offer U.S. fruit and vegetable growers a new way to combat major diseases to maximize yields and extend the shelf life of produce with substantially lower residues.
“Biotalys is thrilled to have begun the EPA registration process for its first product. While Evoca targets diseases like Botrytis cinerea and powdery mildew, we are leveraging the flexibility of our technology platform to advance a broad pipeline of products with new modes of action that will safely and reliably address key crop pests and diseases across the food value chain,” Luc Maertens, COO of Biotalys, said.
Evoca will help growers control key pathogens in the field as well as in the food value chain to protect fruits and vegetables postharvest, extending shelf life and reducing decay and food loss. With its new mode of action and favourable safety profile, Evoca provides growers with additional rotational options to manage resistance in a more sustainable way.
The submission follows Biotalys’ successful completion of an extensive field product development program and regulatory studies on Evoca. More than 200 field and greenhouse trials globally demonstrated high consistency in effective control of key pathogens in fruit and vegetables crops. With this submission and pending regulatory approvals, Biotalys is on track to introduce Evoca to select regions in the U.S. market in late 2022.
Biotalys will proceed with international registrations on its own, maintaining full ownership of all rights. Aligned with the go-to-market strategy for Evoca, the submission in the U.S. will be followed by a submission in the European Union. Major agricultural markets in Latin America and Asia are in scope for future registrations.
Subscribe Today For
